Become A Featured Company

Medical Marijuana Inc. Expands Across the European Union

Ryan Allway

December 8th, 2017

Exclusive, News, Top News

The global market for cannabidiol (CBD) supplements is projected to grow at a nearly 40% compound annual growth rate through 2021, according to Research and Markets, with ecommerce accounting for about 12% of the global retail trade last year. While the industry is very fragmented, Medical Marijuana Inc. (OTC Pink: MJNA) has emerged as one of the only global leaders with a presence in many different countries.

Also see: How to Capitalize on the $1 Billion Hemp Industry

Expansion into Europe

Medical Marijuana Inc. recently announced that its Kannaway® subsidiary has expanded its business into the European market. Using European-sourced materials, the company has created a distribution network for its organic food products that is capable of distribution to all citizens of the European Union as well as other countries outside of the EU. Management believes that the market will be very amenable to Kannaway’s® direct selling strategies.

“We are extremely excited to take this next step in our international expansion by becoming the first direct selling company to feature phytocannabinoid based products in Europe and to share our products, culture, and mission throughout Europe,” said Medical Marijuana Inc. COO Blake Schroeder. “We have always planned to bring our revolutionary products to a worldwide audience, and Europe is the perfect next step for our company.”

Kannaway® is a network sales and marketing company that specializes in hemp-based botanical products. Through weekly online sales meetings and conferences, the company offers unique insights and opportunities to sales professionals. According to the Worldwide Federation of Direct Selling Associations, European direct sales companies generated more than $35 billion in retail sales in 2015, which points to a significant market opportunity.

Existing Global Presence

Medical Marijuana Inc.’s HempMeds business has made significant inroads into many international markets, particularly in Latin America. After several Latin American countries relaxed laws surrounding cannabinoids, the company has been quick to introduce its hemp-based CBD products through proper regulatory channels. The initial win in Mexico was soon joined by wins in countries like Brazil and U.S. territories like Puerto Rico.

Also see: Latin America Embraces Hemp-based CBD Oil

In February 2016, Mexico’s regulatory authority, COFEPRIS, approved the legal import of Real Scientific Hemp Oil-X™ for two young girls suffering from severe epilepsy and the program has expanded into several other medical conditions since then. Brazil later approved the import of Real Scientific Hemp Oil™ through HempMeds Brasil – an affiliate of Medical Marijuana Inc. – for epilepsy, Parkinson’s disease, and chronic pain indications.

Medical Marijuana Inc. has also committed to undergoing clinical trials in other countries to support the use of CBD-based hemp oil. In fact, a recent clinical study in Mexico confirmed the safety and effectiveness of RSHO-X 5000 for the treatment of Lennox Gastaut Syndrome. The study found an 84% reduction in motor seizures with more than half of patients reporting a better than 75% reduction in seizures and 17% reporting a complete remission.

Looking Ahead

Medical Marijuana Inc. (OTC Pink: MJNA) represents a compelling opportunity in the global hemp-based CBD industry. In addition to its existing presence in Latin America, the company’s Kannaway® business recently expanded into Europe. Investors may want to take note of this expansion given the potential to accelerate revenue and unlock long-term value. Investors also benefit from the company’s many other subsidiaries for diversified exposure.

For more information, visit the company’s website at www.medicalmarijuanainc.com.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading